We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+10.2%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$1.08T
AUM Growth
+$79.9B
Cap. Flow
-$8.94B
Cap. Flow %
-0.83%
Top 10 Hldgs %
25.7%
Holding
3,000
New
159
Increased
1,164
Reduced
1,499
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.45B
2
PINS icon
Pinterest
PINS
+$1.89B
3
TMUS icon
T-Mobile US
TMUS
+$1.89B
4
ZM icon
Zoom
ZM
+$1.77B
5
PATH icon
UiPath
PATH
+$1.71B

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$3.66B
2
CAT icon
Caterpillar
CAT
+$1.32B
3
NFLX icon
Netflix
NFLX
+$1.18B
4
MXIM
Maxim Integrated Products
MXIM
+$1.15B
5
MU icon
Micron Technology
MU
+$1.07B

Sector Composition

Rank Sector Weight
1 Technology 24.62%
2 Healthcare 16.07%
3 Consumer Discretionary 15.29%
4 Communication Services 13.46%
5 Financials 12.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KG
2876
Kestrel Group
KG
$66.3M
$62K ﹤0.01%
921
+321
+54% +$22.3K
RNAC icon
2877
Cartesian Therapeutics
RNAC
$263M
$61K ﹤0.01%
+487
New +$58K
BRN icon
2878
Barnwell Industries
BRN
$13.9M
$60K ﹤0.01%
18,200
LTRX icon
2879
Lantronix
LTRX
$275M
$58K ﹤0.01%
11,200
USWS
2880
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$58K ﹤0.01%
2,714
TIO
2881
DELISTED
Tingo Group, Inc. Common Stock
TIO
$57K ﹤0.01%
24,300
VSTM icon
2882
Verastem
VSTM
$629M
$56K ﹤0.01%
1,152
+168
+17% +$7K
INUV icon
2883
Inuvo
INUV
$14.2M
$55K ﹤0.01%
5,660
KDMN
2884
DELISTED
Kadmon Holdings, Inc.
KDMN
$55K ﹤0.01%
14,173
+2,427
+21% +$9.41K
CNVS icon
2885
Cineverse
CNVS
$68.9M
$52K ﹤0.01%
2,005
CRBP icon
2886
Corbus Pharmaceuticals
CRBP
$189M
$52K ﹤0.01%
947
+566
+149% +$31.4K
CLIR icon
2887
ClearSign Technologies
CLIR
$28.1M
$50K ﹤0.01%
1,040
AXAS
2888
DELISTED
Abraxas Petroleum Corp
AXAS
$50K ﹤0.01%
+15,382
New +$40.6K
CATX icon
2889
Perspective Therapeutics
CATX
$372M
$49K ﹤0.01%
6,150
SEEL
2890
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$47K ﹤0.01%
+5
New +$82.2K
AUD
2891
DELISTED
Audacy, Inc.
AUD
$45K ﹤0.01%
+10,472
New +$48.1K
EMWP
2892
DELISTED
Eros Media World PLC
EMWP
$45K ﹤0.01%
1,467
+912
+164% +$24.9K
CEMI
2893
DELISTED
Chembio diagnostics, Inc.
CEMI
$45K ﹤0.01%
15,200
-29,924
-66% -$104K
NAT icon
2894
Nordic American Tanker
NAT
$1.36B
$44K ﹤0.01%
13,462
+3,179
+31% +$10.7K
LPTH icon
2895
Lightpath Technologies
LPTH
$862M
$39K ﹤0.01%
15,300
ASAP
2896
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$33K ﹤0.01%
930
-289
-24% -$13.1K
LGMK
2897
DELISTED
LogicMark
LGMK
$30K ﹤0.01%
7
SVRA icon
2898
Savara
SVRA
$1.17B
$29K ﹤0.01%
17,260
-1,743
-9% -$3.13K
TNXP icon
2899
Tonix Pharmaceuticals
TNXP
$205M
0
XTNT icon
2900
Xtant Medical Holdings
XTNT
$43.5M
$25K ﹤0.01%
15,472
-12,428
-45% -$22.1K

Similar funds

T. Rowe Price Associates's Q2 2021 Portfolio in Review

As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
  • T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
  • T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
  • T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
  • T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
  • T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.

Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.